MORGAN STANLEY - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$114,805
-60.7%
252,318
-42.1%
0.00%
Q2 2023$291,824
+11.2%
435,558
-28.7%
0.00%
Q1 2023$262,548
-8.2%
610,577
-33.4%
0.00%
Q4 2022$285,903
-64.9%
916,649
-34.5%
0.00%
Q3 2022$814,000
-34.8%
1,398,449
-12.6%
0.00%
Q2 2022$1,248,000
-40.9%
1,599,304
-19.7%
0.00%
Q1 2022$2,112,000
+12.5%
1,992,129
-2.4%
0.00%
Q4 2021$1,878,000
-61.0%
2,041,382
-14.4%
0.00%
-100.0%
Q3 2021$4,816,000
-10.7%
2,384,379
-4.9%
0.00%0.0%
Q2 2021$5,391,000
-5.2%
2,507,390
+0.1%
0.00%0.0%
Q1 2021$5,689,000
+218.2%
2,505,954
+150.9%
0.00%
Q4 2020$1,788,000
+3.2%
998,815
+24.0%
0.00%
Q3 2020$1,732,000
+46.5%
805,415
+69.1%
0.00%
Q2 2020$1,182,000
+2469.6%
476,312
+2524.2%
0.00%
Q1 2020$46,00018,151
+23782.9%
0.00%
Q4 2019$0
-100.0%
76
-99.9%
0.00%
Q3 2019$110,000143,8640.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,873$26,0000.12%
GSA CAPITAL PARTNERS LLP 95,754$206,0000.03%
Arkadios Wealth Advisors 20,000$45,400,0000.02%
Bayesian Capital Management, LP 42,200$91,0000.02%
SeaCrest Wealth Management, LLC 50,515$109,0000.02%
Virtu Financial LLC 29,604$64,0000.01%
Traynor Capital Management, Inc. 14,777$31,0000.01%
WEDBUSH SECURITIES INC 13,295$29,0000.00%
Verition Fund Management LLC 40,000$86,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11,600$25,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders